Invvax

Developing patented, novel vaccine technology to prevent pandemics and improve global health

placeLos Angeles, California, United States calendar_todayFounded 2012 groups4 employees language inv-vax.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 680 times.

YearFilings
20181
20191
20201
20211
20221
20231
20251

Investor mix

3 investors on record; lead investors include Crescent Ridge Partners.

Investor typeCountShare
Venture capital133%
Angel & family office133%
Other / undisclosed133%
Coming soon